Table 3 Characteristics and the distribution of deaths for covariates in Dataset 2

Age at diagnosis

Ethionamide

Below 30

35(81.3)

8(18.6)

43

Not prescribed

25(64.10)

14(35.89)

39

Above 30

43(68.25)

20(31.75)

63

Prescribed

54(79.41)

14(20.59)

68

Gender

Ofloxacin

Females

41(83.67)

8(16.33)

49

Not prescribed

48(70.59)

20(29.41)

68

Males

38(65.52)

20(34.48)

58

Prescribed

31(79.49)

8(20.51)

39

smoking status

Ofloxacin and moxifloxacin

No

28(65.12)

15(34.88)

43

Not prescribed

72(72.73)

27(27.27)

99

Yes

38(79.17)

10(20.83)

48

Prescribed

7(87.50)

1(12.50)

8

HIV plus ART status

Amikacin

HIV -ve

46(73.02)

17(26.98)

63

Not prescribed

76(73.79)

27(26.21)

103

HIV +ve ART

24(68.57)

11(31.43)

35

Prescribed

3(75.00)

1(25.00)

4

HIV +ve no ART

9 (100.00)

0 (0.00)

9

Capreomycin

Cohort

Not prescribed

8(88.98)

1(11.11)

9

B

54(83.08)

11(16.92)

65

Prescribed

71(72.45)

27(27.55)

98

N

12(80.00)

3(20.00)

15

Dapsone

S

13(48.15)

14(51.85)

27

Not prescribed

43(67.19)

21(32.81)

64

Race

Prescribed

36(83.72)

7(16.28)

43

Blacks

34(64.15)

19(35.85)

53

Augmentin

Mixed ancestry

45(83.33)

9(16.67)

54

Not prescribed

28(66.67)

14(33.33)

42

Drugs used

Prescribed

51(78.46)

14(21.54)

65

Isoniazid

Clofazamine

Not prescribed

57(83.82)

11(16.18)

68

Not prescribed

70(82.35)

15(17.65)

85

Prescribed

22(56.41)

17(43.59)

39

Prescribed

9(40.91)

13(59.09)

22

Etambutol

Azithromycin

Not prescribed

39(66.10)

20(33.89)

59

Not prescribed

75(76.53)

23(23.47)

98

Prescribed

40(83.33)

8(16.67)

48

Prescribed

4(44.44)

5(55.56)

9

Pyrazinainamide

Amoxicillin

Not prescribed

14(58.33)

10(41.67)

24

Not prescribed

49(71.01)

20(28.99)

69

Prescribed

65(78.3)

18(21.69)

83

Prescribed

30(78.95)

8(21.05)

38

Clarithromycin

Not prescribed

19(70.37)

8(29.63)

27

Prescribed

60(75.00)

20(25.00)

80